Loading...

Apexigen, Inc.

APGNNASDAQ
HealthcareBiotechnology
$0.39
$0.03(8.48%)

Apexigen, Inc. APGN Peers

See (APGN) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
APGN$0.39+8.48%9.6M-0.23-$1.71N/A
VRTX$445.85-0.14%114.5B-116.41-$3.83N/A
REGN$484.83-0.62%51.5B12.32$39.36+0.36%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$305.18+0.46%39.8B-145.32-$2.10N/A
ARGX$573.05-0.62%35B34.98$16.38N/A
BNTX$111.25-3.80%26.7B-30.73-$3.62N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$33.44+0.45%18.8B13.65$2.45+2.56%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

APGN vs VRTX Comparison

APGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APGN stands at 9.6M. In comparison, VRTX has a market cap of 114.5B. Regarding current trading prices, APGN is priced at $0.39, while VRTX trades at $445.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APGN currently has a P/E ratio of -0.23, whereas VRTX's P/E ratio is -116.41. In terms of profitability, APGN's ROE is +0.48%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, APGN is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APGN.

Stock Price Comparison

Loading...

Frequently Asked Questions